Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

v3.23.1
CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Convertible Preferred Stock
Common Stock
Common Stock
Private Placement
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at the beginning (in shares) at Dec. 31, 2020 [1]   77,340,057          
Balance at the beginning at Dec. 31, 2020   $ 75,877          
Convertible Preferred Stock              
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger (in shares) [1]   (77,340,057)          
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger   $ (75,877)          
Balance at the end (in shares) at Dec. 31, 2021 0 0 [1]          
Balance at the end at Dec. 31, 2021   $ 0          
Balance at the beginning (in shares) at Dec. 31, 2020 [1]     9,846,830        
Balance at the beginning at Dec. 31, 2020 $ (84,805)   $ 1   $ 10,110 $ 0 $ (94,916)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of warrants to purchase common stock $ 1       1    
Issuance of common stock upon exercise of stock options (in shares) 2,806,961   4,276,327 [1]        
Issuance of common stock upon exercise of stock options $ 915       915    
Issuance of common stock upon vesting of restricted stock units (in shares) [1]     2,625        
Stock-based compensation expense 8,106       8,106    
Repurchase of common stock upon settlement of related party note (in shares) [1]     (43,665)        
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger (in shares) [1]     80,833,007        
Conversion of convertible preferred stock into common stock in connection with the closing of the Merger 75,877   $ 8   75,869    
Issuance of common stock in connection with the closing of the Merger (in shares) [1]     10,391,513        
Issuance of common stock in connection with the closing of the Merger 84,945   $ 1   84,944    
Issuance of common stock in connection with the consummation of the PIPE Investment (in shares) [1]       30,000,000      
Issuance of common stock in connection with the consummation of the PIPE Investment 300,000     $ 3 299,997    
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger (in shares) [1]     2,029,712        
Issuance of common stock for net settlement of common stock and preferred stock warrants upon settlement of the Merger 880       880    
Issuance of common stock for the conversion of convertible notes (in shares) [1]     5,408,672        
Issuance of common stock for the conversion of convertible notes 53,645   $ 1   53,644    
Issuance of public warrants in connection with the closing of the Merger (23,636)       (23,636)    
Payment of deferred offering costs in connection with the closing of the Merger and PIPE Investment (36,075)       (36,075)    
Initial fair value of contingent earn-out liability recognized upon the closing of the Merger (67,021)       (67,021)    
Initial fair value of contingently issuable common stock liability recognized upon the closing of the Merger (11,670)       (11,670)    
Net income (loss) (10,888)           (10,888)
Cumulative translation adjustment 0            
Balance at the end at Dec. 31, 2021 $ 290,274   $ 14   396,064 0 (105,804)
Balance at the end (in shares) at Dec. 31, 2021 [1]     142,745,021        
Balance at the end (in shares) at Dec. 31, 2022 0 0 [1]          
Balance at the end at Dec. 31, 2022   $ 0          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock upon exercise of stock options (in shares) 1,896,975   1,894,179 [1]        
Issuance of common stock upon exercise of stock options $ 828   $ 1   827    
Issuance of common stock upon vesting of restricted stock units (in shares) [1]     565,774        
Stock-based compensation expense $ 22,299       22,299    
Issuance of common stock in connection with the closing of the Merger (in shares) 10,391,513            
Net income (loss) $ (86,406)           (86,406)
Cumulative translation adjustment (10)         (10)  
Balance at the end at Dec. 31, 2022 $ 226,985   $ 15   $ 419,190 $ (10) $ (192,210)
Balance at the end (in shares) at Dec. 31, 2022 [1]     145,204,974        
[1] The shares of the Company’s convertible preferred stock and common stock, prior to the Merger (as defined in Note 3) have been retrospectively restated to reflect the exchange ratio of 0.378 established in the Merger as described in Note 3.